He added that the operation was carried out immediately and a relevant court ruling was announced within a couple of days. The Ukrainian health ministry is investigating the issue, but it was also surprised that the transaction was carried out. If the situation is not clarified in line with its expectations, Bioton will launch the sale of insulin on the Ukrainian market under its own brand. "We have contacts with Ukrainian distributors and we can launch our own brand within a month," said the president of Bioton. Analysts are skeptical about this emergency plan.
Źródło:
